PDZK2 Activators
PDZK2 Activators encompass a range of chemical compounds that indirectly promote the activity of PDZK2 through distinct signaling pathways. Forskolin, by escalating cAMP levels, indirectly fosters PDZK2's role in cellular signaling by enabling PKA to phosphorylate PDZK2, thereby enhancing its signaling capabilities. This mechanism is shared by IBMX and Rolipram, which prevent cAMP degradation, leading to PKA-mediated phosphorylation of PDZK2 andaugmented activity in signal transduction. Similarly, Sildenafil and Vardenafil, both PDE5 inhibitors, elevate cGMP levels, indirectly leading to the activation of PKG, which can modulate PDZK2 activity. This pathway is shared by the ANP and Zaprinast, which also increase cGMP levels, subsequently activating PKG and indirectly enhancing PDZK2's function. Furthermore, specific activation of Epac by Epac Activator 5376751 through direct cAMP stimulation and the cAMP analogs 8-Br-cAMP and Sp-8-Br-cAMPS provide alternative routes for PKA to influence PDZK2, broadening the spectrum of activation mechanisms.
Inhibition of PDE3 and PDE4D by their respective inhibitors also leads to an increase in cAMP, with subsequent PKA activation, which in turn can phosphorylate PDZK2, bolstering its involvement in lipid metabolism and other cellular functions. The cAMP-mediated activation pathway is a common theme among PDZK2 activators, where the end result is the enhancement of PDZK2's activity through phosphorylation by PKA. These chemicals, while diverse in their primary targets, converge on a common functional outcome: the facilitation of PDZK2's role in cellular signaling networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate PDZK2, enhancing its activity in cellular signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, preventing cAMP and cGMP degradation, which indirectly results in the activation of PKA and PKG, respectively. PKA can then act on PDZK2, increasing its functional activity in processes such as ion transport and receptor signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which increases intracellular cAMP by preventing its breakdown. This selective increase in cAMP results in targeted PKA activation, which could then phosphorylate PDZK2, enhancing its activity in signal transduction. | ||||||
BAY 41-2272 | 256376-24-6 | sc-202491 sc-202491A | 5 mg 25 mg | $238.00 $728.00 | 4 | |
This activator directly stimulates Epac, a guanine nucleotide exchange factor directly activated by cAMP, which in turn can influence PDZK2 by promoting its interaction with partners and substrates in signal transduction pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cAMP analog that activates PKA and Epac, leading to the phosphorylation of PDZK2 or alteration of its interactions within cellular signaling pathways, thereby enhancing its activity. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, notably PDE5, leading to increased cGMP levels, which enhance PKG activation. PKG can then indirectly modulate PDZK2 activity, potentially enhancing its function in cellular signaling pathways. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, a PDE5 inhibitor, increases cGMP levels, which leads to activation of PKG. PKG can then phosphorylate PDZK2 or affect its protein interactions, potentially enhancing its functional activity in signal transduction related to endothelial function and other processes. | ||||||